Regulatory Readiness & Strategy for UK/EU Market Access

The path to market access in the UK and Europe has never been more complex. Post-Brexit divergence, the full implementation of the EU MDR/IVDR, and the emerging EU AI Act have created a labyrinth of new requirements for health tech innovators. 

Medical device compliance is no longer just a box-ticking exercise; it is a critical strategic pillar that defines your product's design, clinical data requirements, and go-to-market timeline. A misstep here doesn't just mean a delay—it can mean being locked out of key markets entirely. At Global MedTech, we ensure your regulatory strategy is fully aligned with your commercial goals and UK EU regulations from day one.

We don't view regulation in isolation. Our "5-Steps Framework" integrates regulatory planning into the earliest stages of your market access strategy. We help you understand: 

Which classification your product truly falls under and the implications for clinical evidence. 

How to design your clinical trials to satisfy both UK (MHRA) and EU (Notified Body) regulations simultaneously, saving time and money. 

The commercial impact of regulatory decisions on reimbursement and procurement models like the NHS.

We provide the high-level roadmap and strategic oversight to ensure your journey to market is as smooth and predictable as possible while ensuring medical device compliance.

UK Market Access (MHRA & UKCA) 

Navigating the post-Brexit landscape is critical for an effective market access strategy. We guide you through the transition to UKCA marking, the specific requirements of the MHRA, and the future regulatory framework for medical devices in Great Britain. Our expertise helps you understand the specific nuances of the UK market, including the Innovative Devices Access Pathway (IDAP), ensuring your medical device compliance in this evolving environment.

EU Market Entry (MDR & IVDR) 

The Medical Device Regulation (MDR 2017/745) and In Vitro Diagnostic Regulation (IVDR 2017/746) have significantly raised the bar for clinical evidence and post-market surveillance. We assist you in conducting gap analyses against these new standards, planning your technical documentation, and preparing for interactions with Notified Bodies to enhance your market access strategy in the EU.

AI & Digital Health Regulation 

AI-driven medical devices face a double challenge: meeting standard medical device regulations plus emerging AI-specific legislation like the EU AI Act. We provide clarity on:

- Determining if your software is a Medical Device (SaMD).

- Navigating AI-specific requirements for transparency, data governance, and human oversight.

- Aligning with standards like the NHS's Digital Technology Assessment Criteria (DTAC) for UK market entry, ensuring compliance with both UK and EU regulations.

At Global MedTech, our focus is on high-level regulatory strategy and its commercial implications, particularly in relation to market access strategy and medical device compliance. For the detailed, hands-on execution of that strategy, including technical file authoring, clinical evaluation report (CER) writing, and quality management system (QMS) implementation, we have a dedicated strategic partnership. We work closely with our sister company, Innovate Health Consulting Ltd., a specialist firm focused on the operational delivery of regulatory and quality projects in line with UK EU regulations. This unique structure provides you with: Integrated Service: A single, cohesive roadmap where strategic decisions are seamlessly translated into operational tasks. Specialist Expertise: Access to a deep bench of regulatory writers, quality auditors, and clinical experts dedicated to the execution phase. Efficiency: No need to manage multiple vendors; we coordinate the entire process. While we define the path, Innovate Health Consulting paves it, ensuring your technical documentation is robust, compliant, and ready for submission.

Don't let regulatory uncertainty stall your market access strategy. Schedule a discovery call with our team to discuss your product and determine your optimal path to medical device compliance under UK EU regulations.